Overview

Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Phase IIa clinical trial, pilot, single centre, prospective, randomized, double-blind, placebo-controlled, with sequential inclusion of patients
Phase:
Phase 2
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz